"Designing Growth Strategies is in our DNA"

Oncology Drugs Market Size, Share & Industry Analysis, By Drugs Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, and Others), By Therapy (Chemotherapy, Targeted Therapy, and Immunotherapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, and Others), By Dosage Form (Solid, Liquid, and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: January 26, 2026 | Format: PDF | Report ID: FBI103431

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and assumptions
  2. executive summary
  3. Market Dynamics
    1. Market Drivers
    2. Market restraint
    3. Market Opportunity
    4. Market Trends
  4. Key Insights
    1. Cancer prevalence, region/country, 2025
    2. Overview of various oncology drugs with regard to regulatory approval and clinical trials
    3. Pricing Analysis, Key Brands/Key Players, 2025
    4. Major industry developments (mergers, acquisitions, partnerships)
    5. Covid-19 market impact
  5. Global Oncology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecasts - By Drug Class
      1. Cytotoxic drugs
        1. Alkylating agents
        2. Antitoxic
        3. others
      2. Targeted drugs
        1. Monoclonal antibodies
        2. others
      3. Hormonal medications
      4. others
    2. Market Analysis, Insights and Forecasts – By Treatment
      1. Chemotherapy
      2. Targeted therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecasts - By Sign
      1. lung cancer
      2. Stomach cancer
      3. Colorectal cancer
      4. Breast cancer
      5. Prostate cancer
      6. others
    4. Market Analysis, Insights and Forecasts - By Dosage Form
      1. solid
        1. tablet
        2. capsule
      2. liquid
      3. Injection may
        1. Prefilled Syringes
        2. others
    5. Market Analysis, Insights and Forecasts - By Distribution Channel
      1. Hospital pharmacy
      2. retail pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecasts - By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. latin america
      5. Middle East and Africa
  6. North America Oncology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecasts - By Drug Class
      1. Cytotoxic drugs
        1. Alkylating agents
        2. Antitoxic
        3. others
      2. Targeted drugs
        1. Monoclonal antibodies
        2. others
      3. Hormonal medications
      4. others
    2. Market Analysis, Insights and Forecasts – By Treatment
      1. Chemotherapy
      2. Targeted therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecasts - By Sign
      1. lung cancer
      2. Stomach cancer
      3. Colorectal cancer
      4. Breast cancer
      5. Prostate cancer
      6. others
    4. Market Analysis, Insights and Forecasts - By Dosage Form
      1. solid
        1. tablet
        2. capsule
      2. liquid
      3. Injection may
        1. Prefilled Syringes
        2. others
    5. Market Analysis, Insights and Forecasts - By Distribution Channel
      1. Hospital pharmacy
      2. retail pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecasts - by Country
      1. Us.
        1. By drug class
      2. Canada
        1. By drug class
  7. Europe Oncology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecasts - By Drug Class
      1. Cytotoxic drugs
        1. Alkylating agents
        2. Antitoxic
        3. others
      2. Targeted drugs
        1. Monoclonal antibodies
        2. others
      3. Hormonal medications
      4. others
    2. Market Analysis, Insights and Forecasts – By Treatment
      1. Chemotherapy
      2. Targeted therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecasts - By Sign
      1. lung cancer
      2. Stomach cancer
      3. Colorectal cancer
      4. Breast cancer
      5. Prostate cancer
      6. others
    4. Market Analysis, Insights and Forecasts - By Dosage Form
      1. solid
        1. tablet
        2. capsule
      2. liquid
      3. Injection may
        1. Prefilled Syringes
        2. others
    5. Market Analysis, Insights and Forecasts - By Distribution Channel
      1. Hospital pharmacy
      2. retail pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecasts - By Country/Sub-Region
      1. UK
        1. By drug class
      2. Germany
        1. By drug class
      3. France
        1. By drug class
      4. Spain
        1. By drug class
      5. Italy
        1. By drug class
      6. Scandinavia
        1. By drug class
      7. Rest of Europe
        1. By drug class
  8. Asia Pacific Medical Oncology Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecasts - By Drug Class
      1. Cytotoxic drugs
        1. Alkylating agents
        2. Antitoxic
        3. others
      2. Targeted drugs
        1. Monoclonal antibodies
        2. others
      3. Hormonal medications
      4. others
    2. Market Analysis, Insights and Forecasts – By Treatment
      1. Chemotherapy
      2. Targeted therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecasts - By Sign
      1. lung cancer
      2. Stomach cancer
      3. Colorectal cancer
      4. Breast cancer
      5. Prostate cancer
      6. others
    4. Market Analysis, Insights and Forecasts - By Dosage Form
      1. solid
        1. tablet
        2. capsule
      2. liquid
      3. Injection may
        1. Prefilled Syringes
        2. others
    5. Market Analysis, Insights and Forecasts - By Distribution Channel
      1. Hospital pharmacy
      2. retail pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecasts - By Country/Sub-Region
      1. Japan
        1. By drug class
      2. China
        1. By drug class
      3. India
        1. By drug class
      4. Australia
        1. By drug class
      5. Southeast Asia
        1. By drug class
      6. Rest of Asia Pacific
        1. By drug class
  9. Latin America Oncology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecasts - By Drug Class
      1. Cytotoxic drugs
        1. Alkylating agents
        2. Antitoxic
        3. others
      2. Targeted drugs
        1. Monoclonal antibodies
        2. others
      3. Hormonal medications
      4. others
    2. Market Analysis, Insights and Forecasts – By Treatment
      1. Chemotherapy
      2. Targeted therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecasts - By Sign
      1. lung cancer
      2. Stomach cancer
      3. Colorectal cancer
      4. Breast cancer
      5. Prostate cancer
      6. others
    4. Market Analysis, Insights and Forecasts - By Dosage Form
      1. solid
        1. tablet
        2. capsule
      2. liquid
      3. Injection may
        1. Prefilled Syringes
        2. others
    5. Market Analysis, Insights and Forecasts - By Distribution Channel
      1. Hospital pharmacy
      2. retail pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecasts - By Country/Sub-Region
      1. Brazil
        1. By drug class
      2. Mexico
        1. By drug class
      3. Rest of Latin America
        1. By drug class
  10. Middle East and Africa Medical Oncology Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecasts - By Drug Class
      1. Cytotoxic drugs
        1. Alkylating agents
        2. Antitoxic
        3. others
      2. Targeted drugs
        1. Monoclonal antibodies
        2. others
      3. Hormonal medications
      4. others
    2. Market Analysis, Insights and Forecasts – By Treatment
      1. Chemotherapy
      2. Targeted therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecasts - By Sign
      1. lung cancer
      2. Stomach cancer
      3. Colorectal cancer
      4. Breast cancer
      5. Prostate cancer
      6. others
    4. Market Analysis, Insights and Forecasts - By Dosage Form
      1. solid
        1. tablet
        2. capsule
      2. liquid
      3. Injection may
        1. Prefilled Syringes
        2. others
    5. Market Analysis, Insights and Forecasts - By Distribution Channel
      1. Hospital pharmacy
      2. retail pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecasts - By Country/Sub-Region
      1. GCC
        1. By drug class
      2. South Africa
        1. By drug class
      3. Rest of the Middle East and Africa
        1. By drug class
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profile
      1. F. Hoffmann-LaRoche Ltd.
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      2. Abbvie、Inc。
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      3. Novartis AG
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      4. Pfizer Inc.
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      5. Bristol-Myers Squibb Company
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      6. glaxosmithkline plc。
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      7. Eli Lilly and Company
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      8. AstraZeneca
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      9. Sanofi
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      10. Bayer AG
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      11. Merck＆Co.、Inc。
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
  1. introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and assumptions
  2. executive summary
  3. Market Dynamics
    1. Market Drivers
    2. Market restraint
    3. Market Opportunity
    4. Market Trends
  4. Key Insights
    1. Cancer prevalence, region/country, 2025
    2. Overview of various oncology drugs with regard to regulatory approval and clinical trials
    3. Pricing Analysis, Key Brands/Key Players, 2025
    4. Major industry developments (mergers, acquisitions, partnerships)
    5. Covid-19 market impact
  5. Global Oncology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecasts - By Drug Class
      1. Cytotoxic drugs
        1. Alkylating agents
        2. Antitoxic
        3. others
      2. Targeted drugs
        1. Monoclonal antibodies
        2. others
      3. Hormonal medications
      4. others
    2. Market Analysis, Insights and Forecasts – By Treatment
      1. Chemotherapy
      2. Targeted therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecasts - By Sign
      1. lung cancer
      2. Stomach cancer
      3. Colorectal cancer
      4. Breast cancer
      5. Prostate cancer
      6. others
    4. Market Analysis, Insights and Forecasts - By Dosage Form
      1. solid
        1. tablet
        2. capsule
      2. liquid
      3. Injection may
        1. Prefilled Syringes
        2. others
    5. Market Analysis, Insights and Forecasts - By Distribution Channel
      1. Hospital pharmacy
      2. retail pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecasts - By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. latin america
      5. Middle East and Africa
  6. North America Oncology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecasts - By Drug Class
      1. Cytotoxic drugs
        1. Alkylating agents
        2. Antitoxic
        3. others
      2. Targeted drugs
        1. Monoclonal antibodies
        2. others
      3. Hormonal medications
      4. others
    2. Market Analysis, Insights and Forecasts – By Treatment
      1. Chemotherapy
      2. Targeted therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecasts - By Sign
      1. lung cancer
      2. Stomach cancer
      3. Colorectal cancer
      4. Breast cancer
      5. Prostate cancer
      6. others
    4. Market Analysis, Insights and Forecasts - By Dosage Form
      1. solid
        1. tablet
        2. capsule
      2. liquid
      3. Injection may
        1. Prefilled Syringes
        2. others
    5. Market Analysis, Insights and Forecasts - By Distribution Channel
      1. Hospital pharmacy
      2. retail pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecasts - by Country
      1. Us.
        1. By drug class
      2. Canada
        1. By drug class
  7. Europe Oncology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecasts - By Drug Class
      1. Cytotoxic drugs
        1. Alkylating agents
        2. Antitoxic
        3. others
      2. Targeted drugs
        1. Monoclonal antibodies
        2. others
      3. Hormonal medications
      4. others
    2. Market Analysis, Insights and Forecasts – By Treatment
      1. Chemotherapy
      2. Targeted therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecasts - By Sign
      1. lung cancer
      2. Stomach cancer
      3. Colorectal cancer
      4. Breast cancer
      5. Prostate cancer
      6. others
    4. Market Analysis, Insights and Forecasts - By Dosage Form
      1. solid
        1. tablet
        2. capsule
      2. liquid
      3. Injection may
        1. Prefilled Syringes
        2. others
    5. Market Analysis, Insights and Forecasts - By Distribution Channel
      1. Hospital pharmacy
      2. retail pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecasts - By Country/Sub-Region
      1. UK
        1. By drug class
      2. Germany
        1. By drug class
      3. France
        1. By drug class
      4. Spain
        1. By drug class
      5. Italy
        1. By drug class
      6. Scandinavia
        1. By drug class
      7. Rest of Europe
        1. By drug class
  8. Asia Pacific Medical Oncology Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecasts - By Drug Class
      1. Cytotoxic drugs
        1. Alkylating agents
        2. Antitoxic
        3. others
      2. Targeted drugs
        1. Monoclonal antibodies
        2. others
      3. Hormonal medications
      4. others
    2. Market Analysis, Insights and Forecasts – By Treatment
      1. Chemotherapy
      2. Targeted therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecasts - By Sign
      1. lung cancer
      2. Stomach cancer
      3. Colorectal cancer
      4. Breast cancer
      5. Prostate cancer
      6. others
    4. Market Analysis, Insights and Forecasts - By Dosage Form
      1. solid
        1. tablet
        2. capsule
      2. liquid
      3. Injection may
        1. Prefilled Syringes
        2. others
    5. Market Analysis, Insights and Forecasts - By Distribution Channel
      1. Hospital pharmacy
      2. retail pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecasts - By Country/Sub-Region
      1. Japan
        1. By drug class
      2. China
        1. By drug class
      3. India
        1. By drug class
      4. Australia
        1. By drug class
      5. Southeast Asia
        1. By drug class
      6. Rest of Asia Pacific
        1. By drug class
  9. Latin America Oncology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecasts - By Drug Class
      1. Cytotoxic drugs
        1. Alkylating agents
        2. Antitoxic
        3. others
      2. Targeted drugs
        1. Monoclonal antibodies
        2. others
      3. Hormonal medications
      4. others
    2. Market Analysis, Insights and Forecasts – By Treatment
      1. Chemotherapy
      2. Targeted therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecasts - By Sign
      1. lung cancer
      2. Stomach cancer
      3. Colorectal cancer
      4. Breast cancer
      5. Prostate cancer
      6. others
    4. Market Analysis, Insights and Forecasts - By Dosage Form
      1. solid
        1. tablet
        2. capsule
      2. liquid
      3. Injection may
        1. Prefilled Syringes
        2. others
    5. Market Analysis, Insights and Forecasts - By Distribution Channel
      1. Hospital pharmacy
      2. retail pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecasts - By Country/Sub-Region
      1. Brazil
        1. By drug class
      2. Mexico
        1. By drug class
      3. Rest of Latin America
        1. By drug class
  10. Middle East and Africa Medical Oncology Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecasts - By Drug Class
      1. Cytotoxic drugs
        1. Alkylating agents
        2. Antitoxic
        3. others
      2. Targeted drugs
        1. Monoclonal antibodies
        2. others
      3. Hormonal medications
      4. others
    2. Market Analysis, Insights and Forecasts – By Treatment
      1. Chemotherapy
      2. Targeted therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecasts - By Sign
      1. lung cancer
      2. Stomach cancer
      3. Colorectal cancer
      4. Breast cancer
      5. Prostate cancer
      6. others
    4. Market Analysis, Insights and Forecasts - By Dosage Form
      1. solid
        1. tablet
        2. capsule
      2. liquid
      3. Injection may
        1. Prefilled Syringes
        2. others
    5. Market Analysis, Insights and Forecasts - By Distribution Channel
      1. Hospital pharmacy
      2. retail pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecasts - By Country/Sub-Region
      1. GCC
        1. By drug class
      2. South Africa
        1. By drug class
      3. Rest of the Middle East and Africa
        1. By drug class
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profile
      1. F. Hoffmann-LaRoche Ltd.
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      2. Abbvie、Inc。
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      3. Novartis AG
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      4. Pfizer Inc.
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      5. Bristol-Myers Squibb Company
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      6. glaxosmithkline plc。
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      7. Eli Lilly and Company
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      8. AstraZeneca
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      9. Sanofi
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      10. Bayer AG
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
      11. Merck＆Co.、Inc。
        1. overview
        2. Products and Services
        3. SWOT analysis
        4. Recent Developments
        5. strategy
        6. Financial (based on availability)
Read Less

Figure 1: Global Oncology Drugs Market Revenue Collapse by Region, 2025 and 2034 (USD Billion, %)

Figure 2: Global Oncology Drugs Market Value Share (%), by Drug Class, 2025 and 2034

Figure 3: Global Oncology Drugs Market Value Share (%), Therapy, 2025 and 2034

Figure 4: Global Oncology Drugs Market Value Share (%), by Indication, 2025 and 2034

Figure 5: Global Oncology Drugs Market Value Share (%), Dosage Form, 2025 and 2034

Figure 6: Global Oncology Drugs Market Value Share (%), Distribution Channel, 2025 and 2034

Figure 7: Global Oncology Drugs Market Value (USD Billion), by Region, 2025 and 2034

Figure 8: North American Oncology Drug Market Value (USD Billion) by Drug Class, 2025 and 2034

Figure 9: North American Oncology Drug Market Value Share (%), Drug Class, 2025

Figure 10: North American Oncology Drug Market Value (USD Billion), Therapy, 2025 and 2034

Figure 11: North American Medical Oncology Market Value Share (%), Therapy, 2025

Figure 12: North American Medical Oncology Market Value (US$ Billion), Indications, 2025 and 2034

Figure 13: North American Oncology Drug Market Value Share (%), Indication, 2025

Figure 14: North American Oncology Drug Market Value (USD Billion) by Dosage Type, 2025 and 2034

Figure 15: North American Oncology Drugs Market Value Share (%), Dosage Form, 2025

Figure 16: North American Oncology Drugs Market Value (USD Billion), Distribution Channel, 2025 and 2034

Figure 17: North American Oncology Drugs Market Value Share (%), Distribution Channel, 2025

Figure 18: North American Oncology Drugs Market Value (USD Billion), by Country, 2025 and 2034

Figure 19: North American Oncology Drugs Market Value Share (%), by Country, 2025

Figure 20: European Oncology Drugs Market Value (USD Billion) by Drug Class, 2025 and 2034

Figure 21: European Medical Oncology Market Value Share (%), Drug Class, 2025

Figure 22: European Medical Oncology Market Value (USD Billion), Therapy, 2025 and 2034

Figure 23: European Oncology Drugs Market Value Share (%), Therapy, 2025

Figure 24: European Oncology Drugs Market Value (USD Billion), Indications, 2025 and 2034

Figure 25: European Oncology Drugs Market Value Share (%), by Indication, 2025

Figure 26: European Oncology Drugs Market Value (USD Billion) by Dosage Type, 2025 and 2034

Figure 27: European Medical Oncology Market Value Share (%), Dosage Form, 2025

Figure 28: European Oncology Drugs Market Value (USD Billion), Distribution Channel, 2025 and 2034

Figure 29: European Medical Oncology Market Value Share (%), Distribution Channel, 2025

Figure 30: European Medical Oncology Market Value (USD Billion), by Country/Sub-Region, 2025 and 2034

Figure 31: European Medical Oncology Market Value Share (%), by Country/Sub-Region, 2025

Figure 32: Asia Pacific Oncology Drugs Market Value (US$ Billion) by Drug Class, 2025 and 2034

Figure 33: Asia Pacific Oncology Drug Market Value Share (%), by Drug Class, 2025

Figure 34: Asia Pacific Oncology Drugs Market Value (USD Billion), 2025 and 2034

Figure 35: Asia Pacific Oncology Drugs Market Value Share (%), Therapy, 2025

Figure 36: Asia Pacific Medical Oncology Market Value (US$ Billion), Indications, 2025 and 2034

Figure 37: Asia Pacific Oncology Drug Market Value Share (%), Indication, 2025

Figure 38: Asia Pacific Oncology Drug Market Value (USD Billion) by Dosage Type, 2025 and 2034

Figure 39: Asia Pacific Oncology Drug Market Value Share (%), Dosage Form, 2025

Figure 40: Asia Pacific Oncology Drugs Market Value (USD Billion) by Distribution Channel, 2025 and 2034

Figure 41: Asia Pacific Oncology Drug Market Value Share (%), Distribution Channel, 2025

Figure 42: Asia Pacific Medical Oncology Market Value (USD Billion), Country/Sub-Region, 2025, 2034

Figure 43: Asia Pacific Oncology Drugs Market Value Share (%), by Country/Sub-Region, 2025

Figure 44: Latin American Oncology Drug Market Value (USD Billion) by Drug Class, 2025 and 2034

Figure 45: Latin America Oncology Drug Market Value Share (%), by Drug Class, 2025

Figure 46: Latin America Oncology Drugs Market Value (USD Billion), Therapy, 2025 and 2034

Figure 47: Latin America Oncology Drug Market Value Share (%), Therapy, 2025

Figure 48: Latin America Oncology Drugs Market Value (USD Billion), Indications, 2025 and 2034

Figure 49: Latin America Oncology Drugs Market Value Share (%), Indication, 2025

Figure 50: Latin America Oncology Drugs Market Value (USD Billion) by Dosage Type, 2025 and 2034

Figure 51: Latin America Oncology Drugs Market Value Share (%), Dosage Form, 2025

Figure 52: Latin America Oncology Drugs Market Value (USD Billion) by Distribution Channel, 2025 and 2034

Figure 53: Latin America Oncology Drugs Market Value Share (%), Distribution Channel, 2025

Figure 54: Latin America Medical Oncology Market Value (USD Billion), by Country/Subregion, 2025 and 2034

Figure 55: Latin America Oncology Drugs Market Value Share (%), by Country/Subregion, 2025

Figure 56: Middle East and Africa Oncology Drug Market Value (USD Billion) by Drug Class, 2025 and 2034

Figure 57: Middle East and Africa Oncology Drugs Market Value Share (%), by Drug Class, 2025

Figure 58: Middle East and Africa Oncology Drug Market Value (USD Billion), Therapy, 2025 and 2034

Figure 59: Middle East and Africa Oncology Drugs Market Value Share (%), Therapy, 2025

Figure 60: Middle East and Africa Medical Oncology Market Value (USD Billion), Indications, 2025 and 2034

Figure 61: Middle East and Africa Oncology Drugs Market Value Share (%), Indication, 2025

Figure 62: Middle East and Africa Oncology Drug Market Value (USD Billion) by Dosage Type, 2025 and 2034

Figure 63: Middle East and Africa Oncology Drugs Market Value Share (%), Dosage Form, 2025

Figure 64: Middle East and Africa Oncology Drugs Market Value (USD Billion), Distribution Channel, 2025 and 2034

Figure 65: Middle East and Africa Oncology Drugs Market Value Share (%), Distribution Channel, 2025

Figure 66: Middle East and Africa Oncology Drugs Market Value (USD Billion), Country/Sub-Region, 2025 and 2034

Figure 67: Middle East and Africa Oncology Drugs Market Value Share (%), by Country/Sub-Region, 2025

Figure 68: Global Oncology Drugs Market Share (%), by Company, 2025

Table 1: Global Oncology Drugs Market Revenue (US$ Billion) Forecast, Drug Class, 2021-2034

Table 2: Global Oncology Drugs Market Revenue (USD Billion) Forecast by Cytotoxic Agents, 2021–2034

Table 3: Global Medical Oncology Market Revenue (USD Billion) by Targeted Drugs Forecast, 2021-2034

Table 4: Global Oncology Drugs Market Revenue (US$ Billion) Forecast, 2021-2034

Table 5: Global Oncology Drugs Market Revenue (USD Billion) Forecast, 2021-2034

Table 6: Global Oncology Drugs Market Revenue (US$ Billion) Forecast, 2021–2034, by Dosage Form

Table 7: Global Oncology Drugs Market Revenue (US$ Billion) Forecast, SOLID, 2021–2034

Table 8: Global Injectable Oncology Drugs Market Revenue (USD Billion) Forecast, 2021-2034

Table 9: Global Oncology Drugs Market Revenue (USD Billion) Forecast, Delivery Channel, 2021–2034

Table 10: Global Oncology Drugs Market Revenue (USD Billion) Forecast, by Region, 2021-2034

Table 11: North American Oncology Drug Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 12: North American Oncology Drug Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 13: North American Oncology Drug Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021–2034

Table 14: North American Oncology Drugs Market Revenue (USD Billion) Forecast, 2021-2034 by Therapy

Table 15: North American Medical Oncology Market Revenue (USD Billion) Forecast, 2021-2034

Table 16: North American Oncology Drugs Market Revenue Forecast (USD Billion), by Dose Form, 2021-2034

Table 17: North American Oncology Drug Market Revenue (USD Billion) Forecast, SOLID, 2021–2034

Table 18: North American Medical Oncology Market Revenue (USD Billion) Forecast, Injectables, 2021–2034

Table 19: North American Oncology Drugs Market Revenue (USD Billion) Forecast, Distribution Channel, 2021-2034

Table 20: North American Oncology Drugs Market Revenue (USD Billion) Forecast, by Country, 2021-2034

Table 21: US Medical Oncology Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 22: U.S. Oncology Drug Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 23: US Medical Oncology Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021–2034

Table 24: Canadian Oncology Drug Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 25: Canadian Oncology Drugs Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 26: Canadian Medical Oncology Market Revenue (US$ Billion) Forecast, Targeted Drugs, 2021-2034

Table 27: European Medical Oncology Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 28: European Medical Oncology Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 29: European Medical Oncology Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021–2034

Table 30: European Oncology Drugs Market Revenue (USD Billion) Forecast, Therapy, 2021-2034

Table 31: European Oncology Drugs Market Revenue (USD Billion) Forecast, 2021-2034

Table 32: European Medical Oncology Market Revenue (USD Billion) Forecast, Dosage Type, 2021-2034

Table 33: European Oncology Drugs Market Revenue (USD Billion) Forecast, SOLID, 2021–2034

Table 34: European Medical Oncology Market Revenue (USD Billion) Forecast, Injectables, 2021-2034

Table 35: European Oncology Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 36: Europe Oncology Drugs Market Revenue (USD Billion) Forecast, by Country/Subregion, 2021-2034

Table 37: UK Medical Oncology Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 38: UK Oncology Drugs Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 39: UK Medical Oncology Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021–2034

Table 40: German Medical Oncology Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 41: Germany Oncology Drugs Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 42: German Oncology Drugs Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021–2034

Table 43: France Oncology Drugs Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 44: France Oncology Drugs Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 45: France Oncology Drugs Market Revenue (US$ Billion) Forecast, Targeted Drugs, 2021–2034

Table 46: Italian Medical Oncology Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 47: Italian Oncology Drugs Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 48: Italian Medical Oncology Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021–2034

Table 49: Spain Oncology Drugs Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 50: Spanish Medical Oncology Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 51: Spain Oncology Drugs Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021–2034

Table 52: Scandinavian Oncology Drugs Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 53: Scandinavian Oncology Drugs Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 54: Scandinavian Oncology Drugs Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021–2034

Table 55: European Medical Oncology Market Revenue (US$ Billion) Forecast, 2021-2034 Forecast (US$ Billion)

Table 56: European Medical Oncology Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 57: European Medical Oncology Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021-2034

Table 58: Asia Pacific Oncology Drugs Market Revenue (US$ Billion) Forecast, Drug Class, 2021-2034

Table 59: Asia Pacific Medical Oncology Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 60: Asia Pacific Oncology Drugs Market Revenue (US$ Billion) Forecast, Targeted Drugs, 2021-2034

Table 61: Asia Pacific Oncology Drugs Market Revenue (USD Billion) Forecast, Therapy, 2021-2034

Table 62: Asia Pacific Oncology Drugs Market Revenue (USD Billion) Forecast, 2021-2034

Table 63: Asia Pacific Medical Oncology Drug Market Revenue (USD Billion) Forecast, by Dosage Form, 2021-2034

Table 64: Asia Pacific Oncology Drug Market Revenue (USD Billion) Forecast, by SOLID, 2021–2034

Table 65: Asia Pacific Oncology Drugs Market Revenue (USD Billion) Forecast, Injectables, 2021-2034

Table 66: Asia Pacific Oncology Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 67: Asia Pacific Oncology Drugs Market Revenue (USD Billion) Forecast, Country/Subregion, 2021-2034

Table 68: China Medical Oncology Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 69: China Medical Oncology Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 70: China Medical Oncology Market Revenue (US$ Billion) Forecast, Targeted Drugs, 2021–2034

Table 71: India Medical Oncology Market Revenue (US$ Billion) Forecast, Drug Class, 2021-2034

Table 72: India Oncology Drugs Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 73: India Medical Oncology Market Revenue (US$ Billion) Forecast, Targeted Drugs, 2021–2034

Table 74: Japan Oncology Drug Market Revenue (US$ Billion) Forecast, Drug Class, 2021-2034

Table 75: Japan Oncology Drug Market Revenue (US$ Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 76: Japan Medical Oncology Market Revenue (US$ Billion) Forecast, Targeted Drugs, 2021–2034

Table 77: Australian Medical Oncology Market Revenue (US$ Billion) Forecast, Drug Class, 2021-2034

Table 78: Australian Medical Oncology Market Revenue (US$ Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 79: Australia Oncology Drugs Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021–2034

Table 80: Southeast Asia Oncology Drugs Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 81: Southeast Asia Oncology Drugs Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 82: Southeast Asia Medical Oncology Market Revenue (US$ Billion) Forecast, Targeted Drugs, 2021-2034

Table 83: Asia Pacific Oncology Drugs Market Revenue (US$ Billion) Forecast, Remaining by 2021-2034

Table 84: Forecast for Rest of Asia Pacific Oncology Drugs Market Revenue (USD Billion), Cytotoxic Drugs, 2021–2034

Table 85: Rest of Asia Pacific Oncology Drug Market Revenue (USD Billion) Forecast by Targeted Drugs, 2021-2034

Table 86: Latin America Medical Oncology Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 87: Latin America Oncology Drugs Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 88: Latin America Oncology Drugs Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021–2034

Table 89: Latin America Medical Oncology Market Revenue (USD Billion) Forecast, Therapy, 2021-2034

Table 90: Latin America Oncology Drugs Market Revenue (USD Billion) Forecast, 2021-2034

Table 91: Latin America Oncology Drugs Market Revenue (USD Billion) Forecast, Dosage Forms, 2021-2034

Table 92: Latin America Medical Oncology Drug Market Revenue (USD Billion) Forecast, SOLID, 2021–2034

Table 93: Latin America Oncology Drugs Market Revenue (USD Billion) Forecast, Injectables, 2021-2034

Table 94: Latin America Oncology Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 95: Latin America Medical Oncology Market Revenue (USD Billion) Forecast, by Country/Subregion, 2021-2034

Table 96: Brazil Oncology Drugs Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 97: Brazil Oncology Drugs Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 98: Brazil Oncology Drugs Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021–2034

Table 99: Mexico Oncology Drug Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 100: Mexico Oncology Drugs Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 101: Mexico Oncology Drugs Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021-2034

Table 102: Remaining Latin American Oncology Drug Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 103: Latin America Medical Oncology Market Revenue (USD Billion) Forecast, by Cytotoxic Drugs, 2021–2034

Table 104: Latin American Oncology Drugs Market Revenue (US$ Billion) Forecast, Targeted Drugs, 2021-2034

Table 105: Middle East & Africa Medical Oncology Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 106: Middle East & Africa Medical Oncology Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 107: Middle East & Africa Medical Oncology Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021-2034

Table 108: Middle East & Africa Medical Oncology Market Revenue (USD Billion) Forecast, 2021-2034

Table 109: Middle East and Africa Medical Oncology Market Revenue (USD Billion) Forecast, 2021-2034

Table 110: Middle East & Africa Oncology Drugs Market Revenue (USD Billion) Forecast, by Dosage Form, 2021-2034

Table 111: Middle East & Africa Oncology Drug Market Revenue (USD Billion) Forecast, SOLID, 2021–2034

Table 112: Middle East & Africa Injectable Oncology Drugs Market Revenue (USD Billion) Forecast, 2021-2034

Table 113: Middle East & Africa Medical Oncology Market Revenue (USD Billion) Forecast, Distribution Channel, 2021-2034

Table 114: Middle East & Africa Medical Oncology Market Revenue (USD Billion) Forecast, Country/Subregion, 2021-2034

Table 115: GCC Oncology Drugs Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 116: GCC Oncology Drugs Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 117: GCC Oncology Drugs Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021–2034

Table 118: South African Oncology Drugs Market Revenue (USD Billion) Forecast, Drug Class, 2021-2034

Table 119: South African Oncology Drugs Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 120: South African Oncology Drugs Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021–2034

Table 121: Middle East & Africa Oncology Drugs Market Revenue (USD Billion) Forecast, Rest by 2021-2034

Table 122: Rest of Middle East & Africa Medical Oncology Market Revenue (USD Billion) Forecast, Cytotoxic Drugs, 2021–2034

Table 123: Rest of Middle East and Africa Oncology Drug Market Revenue (USD Billion) Forecast, Targeted Drugs, 2021–2034

Oncology Drugs Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 190
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports